CLSWeb Main
Caltech Library System
Electronic Theses
                  About | Browse | Search | Caltech Student Instructions

Allen, Matthew John (2003-12-09) Delivery and activation of contrast agents for magnetic resonance imaging. http://resolver.caltech.edu/CaltechETD:etd-12122003-094113


Type of Document Dissertation
Author Allen, Matthew John
URN etd-12122003-094113
Persistent URL http://resolver.caltech.edu/CaltechETD:etd-12122003-094113
Title Delivery and activation of contrast agents for magnetic resonance imaging
Degree PhD
Option Chemistry
Advisory Committee
Advisor Name Title
John Bercaw Committee Chair
Harry Gray Committee Member
Scott Fraser Committee Member
Thomas Meade Committee Member
Keywords
  • gadolinium
  • Alzheimer's disease
  • polyarginine
Date of Defense 2003-12-09
Availability unrestricted
Abstract
Magnetic Resonance Imaging (MRI) has become a powerful tool for noninvasive imaging of living specimens. Magnetic resonance contrast agents containing the paramagnetic ion gadolinium(III) are used to enhance regions, tissues, and cells that are magnetically similar but histologically distinct. To increase the effectiveness of contrast agents, agents responsive to biological phenomena and directed to specific regions need to be developed. These two improvements are related in that many biologically significant molecules are located in specific locations. Therefore, the design, synthesis, and testing of advanced contrast agents are described.

Many interesting biological targets for imaging reside inside the cell membrane. As the current generation of contrast agents is strictly extracellular, a method of intracellular delivery is required in the development of MRI contrast agents. I have developed cationic, polyarginine-oligomers to deliver gadolinium(III)-based contrast agents into the interior of cells. Delivery was confirmed and studied using methods including inductively coupled plasma-mass spectrometry, MRI, and two-photon laser microscopy to image lanthanide-based MRI contrast agents.

A second approach focused on the synthesis of a series of contrast agents designed to cross the blood brain barrier and label A[Beta]-plaques associated with Alzheimer's disease. These agents were found to permeate cell membranes, and the intracellular properties of these agents are compared to the polyarginine agents. Finally, attempts towards the creation of an advanced MRI contrast agent that is chemically activated by matrix metalloproteinases are described.

Files
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  TotalThesis.pdf 1.45 Mb 00:06:44 00:03:27 00:03:01 00:01:30 00:00:07

Browse All Available ETDs by ( Author | Option )

If you have more questions or technical problems, please Contact the Caltech Library System.